SAN DIEGO, Aug. 27, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a leading global pr

QuidelOrtho's 2026 outlook cut highlights deeper China and respiratory risks, while cash use and ris

QuidelOrtho's resilient core growth and $50 million cost plan offer support, but China weakness, cas

QuidelOrtho's 31.7% three-month rally meets resilient core growth and cost savings, but China weakne

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China w

QuidelOrtho Corporation (NASDAQ: QDEL - Get Free Report)'s share price gapped down before the market

US stocks higher, Nasdaq up 300 pts. Dow +0.3%, Nasdaq +1.2%, S&P 500 +0.58%. Materials and Doxi

Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session.

QuidelOrtho Corporation (QDEL) Q2 2026 Earnings Call Transcript

Gainers Doximity (NYSE:DOCS) stock rose 85.1% to $38.25 during Friday's pre-market session. The

US stock futures mixed, Nasdaq 100 futures up 100 points. Trade Desk Inc shares down 27.7% after wea

QuidelOrtho NASDAQ: QDEL reported second-quarter revenue growth despite continued pressure from Chin

Atlassian Corp (NASDAQ: TEAM) reported strong Q4 results, beating revenue and earnings estimates. St

QuidelOrtho (QDEL) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus

Gainers Doximity (NYSE:DOCS) stock increased by 65.6% to $34.22 during Thursday's after-market

QuidelOrtho (NASDAQ:QDEL) lowers FY2026 Adj EPS guidance from $1.80-$2.00 to $0.65-$0.90 vs $1.84 an

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.13 per share which beat the analyst cons

― Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Car

Investors need to pay close attention to QDEL stock based on the movements in the options market lat

Edgestream Partners L.P. purchased a new stake in QuidelOrtho Corporation (NASDAQ: QDEL) in the unde

QuidelOrtho to Report Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, July 24, 2026

SAN DIEGO, July 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "Q

QDEL's strong portfolio, cost-saving progress and mixed first-quarter results support growth, though

SAN DIEGO, July 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of

Investor litigation firm [url="]Kaskela Law[/url] announces that it is investigating QuidelOrtho Cor

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigati

Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation

SAN DIEGO, July 15, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL)("QuidelOrtho"), a le

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:QDEL) with a Underweight and raise

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 284.8% to $11.39 during Monday

Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: Quid

Seasoned medical technology finance executive brings more than two decades of leadership at global p

Jefferies analyst Tycho Peterson downgrades QuidelOrtho (NASDAQ:QDEL) from Buy to Hold and lowers

Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers

– Marks a Milestone in QuidelOrtho's Plans to Accelerate Growth in Point-of-Care Molecular Diagn

QuidelOrtho (QDEL) stock hits 52-week low as Q1 revenue of $615M-$620M misses targets. China snags a

U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopha

J B Hunt Transport Services Inc (JBHT) stock rose in pre-market trading after beating earnings estim

QDEL stock drops in after-hours trading on Wednesday as QuidelOrtho reports weak Q1 revenue outlook

QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global lea

UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target

QuidelOrtho (NASDAQ:QDEL) is looking for FY2026 Adj EPS of $2.00-$2.42 vs $2.51 analyst estimate. se

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.46 per share which beat the analyst cons